Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Domanović, R. Tedder, J. Blümel, H. Zaaijer, P. Gallian, C. Niederhauser, S. Oliveras, J. O’Riordan, F. Boland, L. Harritshøj, M. Nascimento, A. Ciccaglione, C. Politis, C. Adlhoch, B. Flan, W. Oualikene-Gonin, G. Rautmann, P. Strengers, P. Hewitt (2017)
Hepatitis E and blood donation safety in selected European countries: a shift to screening?Eurosurveillance, 22
F. Hoecke, T. Maerken, M. Boulle, A. Geerts, Van Vlierberghe, I. Colle, H. Padalko (2012)
Hepatitis E seroprevalence in east and west Flanders, Belgium.Acta gastro-enterologica Belgica, 75 3
J. O’Riordan, F. Boland, P. Williams, J. Donnellan, B. Hogema, S. Ijaz, W. Murphy (2016)
Hepatitis E virus infection in the Irish blood donor populationTransfusion, 56
F. Ren, Chenyan Zhao, Ling Wang, Zhuo Wang, Xiao-yan Gong, Mei-lan Song, H. Zhuang, Y. Huang, H. Shan, Jing-xing Wang, Qiang Liu, P. Ness, K. Nelson, Youchun Wang (2014)
Hepatitis E virus seroprevalence and molecular study among blood donors in ChinaTransfusion, 54
N. Roth, W. Schäfer, Rickyn Alexander, K. Elliott, Wlenyeno Elliott‐Browne, Jonathan Knowles, J. Wenzel, T. Simon (2017)
Low hepatitis E virus RNA prevalence in a large‐scale survey of United States source plasma donorsTransfusion, 57
K. Nelson (2017)
Transfusion transmission of hepatitis E virus: an emerging issueAnnals of Botany, 2
H. Lange, J. Øverbø, K. Borgen, S. Dudman, G. Hoddevik, A. Urdahl, L. Vold, S. Sjurseth (2016)
Hepatitis E in Norway: seroprevalence in humans and swineEpidemiology and Infection, 145
Litchia Weber, L. Roberts, J. Sweeney (2014)
Residual plasma in red blood cells and transfusion‐related acute lung injuryTransfusion, 54
A. Cleland, L. Smith, C. Crossan, O. Blatchford, H. Dalton, L. Scobie, J. Petrik, J. Petrik (2013)
Hepatitis E virus in Scottish blood donorsVox Sanguinis, 105
A. Seltsam (2017)
Pathogen Inactivation of Cellular Blood Products—An Additional Safety Layer in Transfusion MedicineFrontiers in Medicine, 4
T. Vollmer, C. Knabbe, J. Dreier (2016)
Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor ScreeningTransfusion Medicine and Hemotherapy, 43
E. Slot, B. Hogema, A. Riezebos‐Brilman, T. Kok, M. Molier, H. Zaaijer (2013)
Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 18 31
I. Sayed, Ann‐Sofie Vercouter, S. Abdelwahab, K. Vercauteren, P. Meuleman (2015)
Is hepatitis E virus an emerging problem in industrialized countries?Hepatology, 62
J. Pawlotsky (2014)
Hepatitis E screening for blood donations: an urgent need?The Lancet, 384
H. Lewis, O. Wichmann, E. Duizer (2009)
Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic reviewEpidemiology and Infection, 138
(2016)
Recommendations from the expert advisory committee on the safety of blood, tissues and organs, on measures to protect patients from acquiring hepatitis E virus via transfusion and transplantation
S. Ijaz, A. Vyse, D. Morgan, R. Pebody, R. Tedder, David Brown (2009)
Indigenous hepatitis E virus infection in England: more common than it seems.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 44 4
K. Borgen, T. Herremans, E. Duizer, H. Vennema, S. Rutjes, A. Bosman, A. Husman, M. Koopmans (2008)
Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; A case series 2004 – 2006BMC Infectious Diseases, 8
L. Hauser, A. Roque-Afonso, A. Beylouné, M. Simonet, B. Fischer, N. Roziers, V. Mallet, P. Tiberghien, P. Bierling (2014)
Hepatitis E transmission by transfusion of Intercept blood system-treated plasma.Blood, 123 5
N. Kamar, H. Dalton, F. Abravanel, J. Izopet (2014)
Hepatitis E Virus InfectionClinical Microbiology Reviews, 27
D. Westhölter, J. Hiller, U. Denzer, S. Polywka, F. Ayuk, M. Rybczynski, T. Horvatits, Svantje Gundlach, Johanna Blöcker, J. Wiesch, N. Fischer, M. Addo, S. Peine, B. Göke, A. Lohse, M. Lütgehetmann, S. Pischke (2018)
HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients.Journal of hepatology, 69 1
Takashi Owada, Moe Kaneko, C. Matsumoto, R. Sobata, Masashige Igarashi, Kou Suzuki, K. Matsubayashi, K. Mio, S. Uchida, M. Satake, K. Tadokoro (2014)
Establishment of culture systems for Genotypes 3 and 4 hepatitis E virus (HEV) obtained from human blood and application of HEV inactivation using a pathogen reduction technology systemTransfusion, 54
P. Hewitt, S. Ijaz, S. Brailsford, R. Brett, S. Dicks, B. Haywood, Iain Kennedy, A. Kitchen, P. Patel, J. Poh, K. Russell, K. Tettmar, J. Tossell, I. Ushiro-Lumb, R. Tedder (2014)
Hepatitis E virus in blood components: a prevalence and transmission study in southeast EnglandThe Lancet, 384
G. Pauli, M. Aepfelbacher, Ursula Bauerfeind, Johannes Blümel, Reinhard Burger, B. Gärtner, Albrecht Gröner, Lutz Gürtler, Margarethe Heiden, Martin Hildebrandt, Bernd Jansen, R. Offergeld, Uwe Schlenkrich, Volkmar Schottstedt, R. Seitz, Johanna Strobel, H. Willkommen, S. Baylis (2015)
Hepatitis E VirusTransfusion Medicine and Hemotherapy, 42
S. Ijaz, E. Arnold, M. Banks, R. Bendall, M. Cramp, R. Cunningham, H. Dalton, T. Harrison, S. Hill, L. Macfarlane, R. Meigh, S. Shafi, M. Sheppard, J. Smithson, M.P. Wilson, C. Teo (2005)
Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics.The Journal of infectious diseases, 192 7
P. Clemente-Casares, Carlota Ramos-Romero, Eugenio Ramirez-Gonzalez, A. Mas (2016)
Hepatitis E Virus in Industrialized Countries: The Silent ThreatBioMed Research International, 2016
Transmission of hepatitis E virus (HEV) through transfusion of blood components has already been reported in several European countries. Here, we assessed the HEV prevalence in Flemish blood donors. This study is of importance in order to assess the risk of HEV transmission through blood transfusion. We analysed 38 137 blood donation samples that were collected by the Red Cross Flanders during the period May‐June 2015. All samples were screened for the presence of HEV RNA and a selection for HEV‐specific IgM/IgG. After pooling per 6, 11 pools reacted positive during RNA screening. Reactive pools were deconstructed, and individual samples were retested. After deconstruction, seven samples were confirmed as HEV RNA positive. Serological screening of the confirmed RNA‐positive samples showed that six out of these seven samples were HEV IgM positive, of which three donors were also IgG positive. Serological screening was also performed on the samples that constituted the four initially HEV RNA reactive pools where RNA positivity was not confirmed on the individual level. In three pools, we found indirect evidence of recent HEV exposure. Within 356 randomly selected samples, 31 donations were HEV IgG positive. Here we show that at least 1:5448 of blood donations in Flanders may originate from donors that are actively infected with HEV. Upon transfusion, these donations may pose a major threat towards patients at risk. Finally, a serological analysis showed that the anti‐HEV IgG prevalence in Flemish blood donors is 8.71%.
Journal of Viral Hepatitis – Wiley
Published: Oct 1, 2019
Keywords: ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.